Behandlung der psoriasis mit biologics

Translated title of the contribution: Treatment of psoriasis with biologics

Rebekka Salgo, Diamant Thaçi*

*Corresponding author for this work


Psoriasis is a chronic-inflammatory skin disease. In case of moderate and severe psoriasis (approximately 20-30 % of all patients), systemic treatment is necessary. Recent findings regarding the pathomechanism of psoriasis led to the development of targeting molecules, so-called biologics. These biotechnical products are able to selectively block mediators that are relevant for inflammation or to block the interaction between cells, imitating or inhibiting natural proteins.

Translated title of the contributionTreatment of psoriasis with biologics
Original languageGerman
Issue number1
Pages (from-to)6-9
Number of pages4
Publication statusPublished - 02.2007

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)


Dive into the research topics of 'Treatment of psoriasis with biologics'. Together they form a unique fingerprint.

Cite this